MCHS-RED CEDAR — History
CCN 521340 | 3-year financial timeline | COVID resilience: 79/100
🛡️ Public data only — no PHI permitted on this instance.
$123M
Latest Revenue (FY2022)
+9.8%
Revenue CAGR (3yr)
16.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $102M | $126M | $123M | -2.3% | +9.8% |
| Operating Expenses | $95M | $104M | $103M | -1.3% | +4.1% |
| Operating Margin | 7.6% | 17.7% | 16.8% | -5.1% | +48.9% |
| Net Income | $8M | $22M | $21M | -7.3% | +63.4% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 4,740 | 5,534 | 5,912 | +6.8% | +11.7% |
| Medicare Day % | 64% | 53% | 57% | +8.9% | -5.5% |
| Medicaid Day % | 9% | 9% | 9% | -2.6% | +0.0% |
COVID Impact & Recovery
Resilience Score: 79/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +20.5% ($102M → $123M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+9.8%
This Hospital
+7.6%
State Avg
Latest Margin
16.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $134M | 21.4% |
| FY2024 (proj) | $144M | 26.0% |
| FY2025 (proj) | $155M | 30.6% |